Ligand Pharmaceuticals
LGND
#3601
Rank
NZ$6.29 B
Marketcap
NZ$320.01
Share price
-1.93%
Change (1 day)
52.41%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$2.55 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total assets are NZ$2.55 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Ligand Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$1.66 B34.15%
2023-12-31NZ$1.24 B3.63%
2022-12-31NZ$1.20 B-36.77%
2021-12-31NZ$1.89 B0.62%
2020-12-31NZ$1.88 B-14.94%
2019-12-31NZ$2.21 B18.09%
2018-12-31NZ$1.87 B98.94%
2017-12-31NZ$0.94 B8.79%
2016-12-31NZ$0.86 B18.16%
2015-12-31NZ$0.73 B123.19%
2014-12-31NZ$0.32 B158.44%
2013-12-31NZ$0.12 B0.54%
2012-12-31NZ$0.12 B-17.97%
2011-12-31NZ$0.15 B57.75%
2010-12-31NZ$97.93 M-49.84%
2009-12-31NZ$0.19 B-33.92%
2008-12-31NZ$0.29 B30.6%
2007-12-31NZ$0.22 B-51.12%
2006-12-31NZ$0.46 B0.55%
2005-12-31NZ$0.46 B-1.21%
2004-12-31NZ$0.46 B-3.56%
2003-12-31NZ$0.48 B-8.2%
2002-12-31NZ$0.52 B86.03%
2001-12-31NZ$0.28 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
NZ$156.03 B 6,003.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$0.18 B-92.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$142.73 B 5,483.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$224.24 B 8,672.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 14,034.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$198.95 B 7,682.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 6,460.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$36.46 B 1,326.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.76 B 12,956.60%๐Ÿ‡บ๐Ÿ‡ธ USA